Protecting brain cells with cannabinol

LA JOLLA—One in every 10 individuals above the age of 65 develops an age-related neurological disorder like Alzheimer’s or Parkinson’s, yet treatment options remain sparse for this population. Scientists have begun exploring whether cannabinoids—compounds derived from the cannabis plant, like well-known THC (tetrahydrocannabinol) and CBD (cannabidiol)—may offer a solution. A third, lesser-known cannabinoid called CBN (cannabinol) has recently piqued the interest of researchers, who have begun exploring the clinical potential of the milder, less psychoactive substance.

The outline of a person and their brain facing a cannabis leaf and symbolic CBN pill, demonstrating the potential for CBN to treat neurological disorders in the future.
The outline of a person and their brain facing a cannabis leaf and symbolic CBN pill, demonstrating the potential for CBN to treat neurological disorders in the future.
Click here for a high-resolution…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks